↓ Skip to main content

TNF Antagonists Opened the Way to Personalized Medicine in Rheumatoid Arthritis

Overview of attention for article published in Molecular Medicine, December 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
18 Mendeley
Title
TNF Antagonists Opened the Way to Personalized Medicine in Rheumatoid Arthritis
Published in
Molecular Medicine, December 2014
DOI 10.2119/molmed.2014.00168
Pubmed ID
Authors

Ferry Breedveld

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease resulting from a largely unknown interaction between genetically determined and environmental factors. Progress in the understanding of this chronic inflammation in the synovial lining of joints has led to the insight that one cytokine, tumor necrosis factor (TNF), has an important role. This insight started the development of a series of targeted and highly effective therapeutics for RA and a range of other autoinflammatory diseases. RA has changed from a severely debilitating disease into a disease where progression can be stopped in most of the patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 17%
Student > Ph. D. Student 3 17%
Student > Master 2 11%
Researcher 2 11%
Professor > Associate Professor 1 6%
Other 0 0%
Unknown 7 39%
Readers by discipline Count As %
Medicine and Dentistry 6 33%
Immunology and Microbiology 3 17%
Environmental Science 1 6%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2015.
All research outputs
#17,774,112
of 22,829,083 outputs
Outputs from Molecular Medicine
#882
of 1,138 outputs
Outputs of similar age
#242,887
of 354,592 outputs
Outputs of similar age from Molecular Medicine
#9
of 16 outputs
Altmetric has tracked 22,829,083 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,138 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,592 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.